Micro-Tech Nanjing Co Ltd
SSE:688029
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (22.8), the stock would be worth ¥90.27 (21% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 18.9 | ¥74.7 |
0%
|
| 3-Year Average | 22.8 | ¥90.27 |
+21%
|
| 5-Year Average | 35.9 | ¥142.06 |
+90%
|
| Industry Average | 29.4 | ¥116.38 |
+56%
|
| Country Average | 28.9 | ¥114.35 |
+53%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
¥13.2B
|
/ |
Oct 2025
¥640.4m
|
= |
|
|
¥13.2B
|
/ |
Dec 2025
¥752.5m
|
= |
|
|
¥13.2B
|
/ |
Dec 2026
¥898.4m
|
= |
|
|
¥13.2B
|
/ |
Dec 2027
¥1B
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
M
|
Micro-Tech Nanjing Co Ltd
SSE:688029
|
14B CNY | 18.9 | 23 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.8B USD | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.7T JPY | 33.6 | 38.6 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.2B CHF | 28 | 37.3 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
94.7B DKK | 14.9 | 23.5 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.5B USD | 19.7 | 33 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP | 17.9 | 32.7 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | 54.5 | -15.5 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
890.2B JPY | 32.4 | 50.3 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
36.7B CNY | 20.9 | 23.3 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8T KRW | -76.7 | -36.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 16.6 |
| Median | 28.9 |
| 70th Percentile | 52.9 |
| Max | 49 021 |
Other Multiples
Micro-Tech Nanjing Co Ltd
Glance View
In the landscape of global endoscopy equipment, Micro-Tech Nanjing Co Ltd. emerges as a crucial player, vividly representing the confluence of precision medical engineering and relentless innovation. Founded in 2000, this Chinese medical device company has carved out a notable niche, specializing primarily in minimally invasive medical devices. Micro-Tech's extensive product line, which includes disposable accessories for endoscopy and interventional pulmonology, forms the backbone of its business. At its core, the company thrives on offering solutions that reduce complication rates in medical procedures and enhance patient outcomes, an endeavor that mirrors the evolving demands of modern healthcare systems worldwide. Micro-Tech's revenue model is intricately woven through its vast network of sales and distribution channels. The company employs a strategy that emphasizes direct sales to hospitals and clinics, alongside collaborations with global distributors, to ensure its products reach a wide array of healthcare professionals. This approach not only amplifies its market presence across various continents but also ensures a steady stream of revenue. By continuously investing in research and development, Micro-Tech stays at the forefront of technological advancements in its field, thus maintaining a competitive edge and ensuring a robust pipeline of innovative products that address the dynamic needs of the healthcare sector.
